 The primary targets for pradofloxacin are the bacterial DNA gyrase and topoisomerase IV enzymes.Reversible association between pradofloxacin and DNA gyrase or DNA topoisomerase IV in the target bacteria results in inhibition of these enzymes and rapid death of the bacterial cell.The rapidity and extent of bacterial killing are directly proportional to the drug concentration.